Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Nyxoah ( (NYXH) ).
Nyxoah SA has announced a transparency notification regarding a passive threshold crossing by Cochlear Investments Pty Ltd, which now holds 14.999% of Nyxoah’s voting rights. This change reflects a slight decrease from a previous 15.04% stake, indicating a minor shift in shareholder structure, which may influence future company decisions and stakeholder interests.
The most recent analyst rating on (NYXH) stock is a Buy with a EUR12.00 price target. To see the full list of analyst forecasts on Nyxoah stock, see the NYXH Stock Forecast page.
More about Nyxoah
Nyxoah operates in the medical technology industry, focusing on the development and commercialization of innovative solutions for sleep apnea treatment. The company is known for its minimally invasive neurostimulation therapy aimed at addressing obstructive sleep apnea, a prevalent condition affecting millions globally.
Average Trading Volume: 58,712
Current Market Cap: €185.6M
For an in-depth examination of NYXH stock, go to TipRanks’ Overview page.